These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18989794)

  • 21. Different expression pattern and significance of p14ARF-Mdm2-p53 pathway and Bmi-1 exist between gastric cardia and distal gastric adenocarcinoma.
    Yao D; Wang Y; Xue L; Wang H; Zhang J; Zhang X
    Hum Pathol; 2013 May; 44(5):844-51. PubMed ID: 23159155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S100 proteins interact with the N-terminal domain of MDM2.
    van Dieck J; Lum JK; Teufel DP; Fersht AR
    FEBS Lett; 2010 Aug; 584(15):3269-74. PubMed ID: 20591429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDM2 mRNA expression in the p53 pathway may predict the potential of invasion and liver metastasis in colorectal cancer.
    Kondo I; Iida S; Takagi Y; Sugihara K
    Dis Colon Rectum; 2008 Sep; 51(9):1395-402. PubMed ID: 18607552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.
    Llanos S; Clark PA; Rowe J; Peters G
    Nat Cell Biol; 2001 May; 3(5):445-52. PubMed ID: 11331871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.
    Wang YC; Lin RK; Tan YH; Chen JT; Chen CY; Wang YC
    J Clin Oncol; 2005 Jan; 23(1):154-64. PubMed ID: 15625370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells.
    Kashuba E; Mattsson K; Pokrovskaja K; Kiss C; Protopopova M; Ehlin-Henriksson B; Klein G; Szekely L
    Int J Cancer; 2003 Jul; 105(5):644-53. PubMed ID: 12740913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDM2 mediates nonproteolytic polyubiquitylation of the DEAD-Box RNA helicase DDX24.
    Yamauchi T; Nishiyama M; Moroishi T; Yumimoto K; Nakayama KI
    Mol Cell Biol; 2014 Sep; 34(17):3321-40. PubMed ID: 24980433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts.
    Khan S; Guevara C; Fujii G; Parry D
    Oncogene; 2004 Aug; 23(36):6040-6. PubMed ID: 15195142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
    Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
    Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Injury of L-02 hepatocytes induced by NaAsO
    Wang T; Zhao Z; Mu Y; Xie T; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jun; 36(6):507-512. PubMed ID: 32696740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
    Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
    Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MDM2-mediated degradation of p14ARF: a novel mechanism to control ARF levels in cancer cells.
    Vivo M; Matarese M; Sepe M; Di Martino R; Festa L; Calabrò V; La Mantia G; Pollice A
    PLoS One; 2015; 10(2):e0117252. PubMed ID: 25723571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy.
    Lu Y; Nikolovska-Coleska Z; Fang X; Gao W; Shangary S; Qiu S; Qin D; Wang S
    J Med Chem; 2006 Jun; 49(13):3759-62. PubMed ID: 16789731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.
    Van Maerken T; Vandesompele J; Rihani A; De Paepe A; Speleman F
    Cell Death Differ; 2009 Dec; 16(12):1563-72. PubMed ID: 19779493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway.
    Horn HF; Vousden KH
    Oncogene; 2008 Oct; 27(44):5774-84. PubMed ID: 18560357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
    Yin Y; Stephen CW; Luciani MG; Fåhraeus R
    Nat Cell Biol; 2002 Jun; 4(6):462-7. PubMed ID: 12032546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulation-based validation of the p53 transcriptional activity with hybrid functional petri net.
    Doi A; Nagasaki M; Matsuno H; Miyano S
    In Silico Biol; 2006; 6(1-2):1-13. PubMed ID: 16789909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma.
    Mascaux C; Bex F; Martin B; Burny A; Haller A; Paesmans M; Willard-Gallo K; Ninane V; Sculier JP
    Eur Respir J; 2008 Sep; 32(3):678-86. PubMed ID: 18480108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunction of p53 pathway in human colorectal cancer: analysis of p53 gene mutation and the expression of the p53-associated factors p14ARF, p33ING1, p21WAF1 and MDM2.
    Tachibana M; Kawamata H; Fujimori T; Omotehara F; Horiuchi H; Ohkura Y; Igarashi S; Kotake K; Kubota K
    Int J Oncol; 2004 Oct; 25(4):913-20. PubMed ID: 15375540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.